Local Institution - 0002 — Boston, Massachusetts

Local Institution - 0002 is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 0002 has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Hodgkin Disease, Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer.

Sponsors: Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0002?

Local Institution - 0002 has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0002 conducted?

Local Institution - 0002 has 8 clinical trials on record, with 2 currently active. Their work covers Hodgkin Disease, Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer.

Is Local Institution - 0002 accredited by Crixeo Health?

Local Institution - 0002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.